Acorah Software Products - Accounts Production 19.3.550 false true 30 September 2024 1 October 2023 false true No description of principal activity 1 October 2024 30 September 2025 30 September 2025 08684043 Jane Braithwaite iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 08684043 2024-09-30 08684043 2025-09-30 08684043 2024-10-01 2025-09-30 08684043 frs-core:CurrentFinancialInstruments 2025-09-30 08684043 frs-core:Non-currentFinancialInstruments 2025-09-30 08684043 frs-bus:PrivateLimitedCompanyLtd 2024-10-01 2025-09-30 08684043 frs-bus:FilletedAccounts 2024-10-01 2025-09-30 08684043 frs-bus:Micro-entities 2024-10-01 2025-09-30 08684043 frs-bus:AuditExempt-NoAccountantsReport 2024-10-01 2025-09-30 08684043 frs-bus:Director1 2024-10-01 2025-09-30 08684043 frs-bus:Director1 2024-09-30 08684043 frs-bus:Director1 2025-09-30 08684043 2023-09-30 08684043 2024-09-30 08684043 2023-10-01 2024-09-30 08684043 frs-core:CurrentFinancialInstruments 2024-09-30 08684043 frs-core:Non-currentFinancialInstruments 2024-09-30
Registered number: 08684043
Designated Medical Ltd
Unaudited Financial Statements
For The Year Ended 30 September 2025
Grid Accounting Ltd
Statement of Financial Position
Registered number: 08684043
2025 2024
£ £
Fixed assets 10,441 15,080
Current assets 145,242 42,624
Prepayments and accrued income 95,119 44,541
Creditors: Amounts Falling Due Within One Year (360,310 ) (167,577 )
NET CURRENT LIABILITIES (119,949 ) (80,412 )
TOTAL ASSETS LESS CURRENT LIABILITIES (109,508 ) (65,332 )
Creditors: Amounts Falling Due After More Than One Year (49,420 ) (32,745 )
Accruals and deferred income (80,622 ) (6,631 )
NET LIABILITIES (239,550 ) (104,708 )
CAPITAL AND RESERVES (239,550 ) (104,708 )

Notes

1. General Information
Designated Medical Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 08684043 . The registered office is LONDON (W1W 5PF) OFFICE, 167-169 GREAT PORTLAND STREET, LONDON, W1W 5PF.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 37 (2024: 25)
37 25
3. Directors Advances, Credits and Guarantees
Included within Debtors are the following loans to directors:
As at 1 October 2024 Amounts advanced Amounts repaid Amounts written off As at 30 September 2025
£ £ £ £ £
Jane Braithwaite 2,562 81,597 57,041 - 27,118
The above loan is unsecured and has been repaid in full by 20/07/2026.
Interest is charged on overdrawn loan accounts at the HMRC interest rate.
4. Going concern
The financial statements have been prepared on a going concern basis which assumes that the company will continue in operational existence for the forseeable future. 
The validity of this assumption depends on the company being able to trade profitably in the future and the continued support of the companys' directors who are also shareholders. The financial statements do not include any adjustments that would result if the company continued to make losses and such support were withdrawn. If the company was unable to continue to trade, adjustments would have to be made to reduce the value of assets to their recoverable amounts, provide for futher liabilities that may arise and to reclassify fixed assets and long term liabilities as current assets and liabilities. The shareholders and directors have expressed their willingness to continue supporting the company for the forseeable future and hence it is appropriate for the financial statements to be prepared on a going concern basis. 
Page 0
Page 1
For the year ending 30 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Jane Braithwaite
Director
20/07/2026